NVEC vs SRPT · P/E 35, rev $25.9M vs rev $1.90B
NVE Corporation (NVEC) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
NVE Corporation (NVEC) is a semiconductors company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported NVEC revenue for 2025-03-31 was $25.9M. Net income was $15.1M. Revenue was down 13.2% from 2024-03-31 to 2025-03-31. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
NVEC currently screens at market cap $527.6M and trailing P/E 34.7. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the NVEC and SRPT stock pages for the full models.
Not investment advice.